11 July 2023
11 July 2023
The Clinical Trials Arena team also review assets in oncology, ophthalmology, and genitourinary system indications.
The Phase III study will involve approximately 900 patients over 65 years of age with severe sarcopenia, low walking speed and low grip strength.
Galmed will use OnKai’s AI models to find the right patients for its upcoming Phase IIa trial in a rare liver disease.
The company completes a preliminary analysis after the FDA found the trial design acceptable for accelerated approval.
SPG302 showed improvements in cognition and motor behaviors in several animal models of neurodegenerative disorders.
The gene therapy for hearing loss treats otoferlin deficiency, an important protein for signal transduction in the ear.
The clinical trial will evaluate the use of the system for the treatment of COPD.
Rate of treated bleeds in the observation period compared with the first 24 weeks treated with SerpinPC is the primary efficacy endpoint.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
